Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro (2021)
Silva, Rai Campos 
; Freitas, Humberto F.; Campos, Joaquín M.; Kimani, Njogu M.; Silva, Carlos Henrique Tomich de Paula da ; Borges, Rosivaldo S.; Pita, Samuel S. R.; Santos, Cleydson B. R.
Source: International Journal of Molecular Sciences. Unidades: FCFRP, FFCLRP
Subjects: COVID-19, PRODUTOS NATURAIS, SAÚDE PÚBLICA, FARMACOCINÉTICA, ANÁLISE TOXICOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Rai Campos et al. Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro. International Journal of Molecular Sciences, v. 22, n. 21, p. 1-24, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms222111739. Acesso em: 04 nov. 2024.APA
Silva, R. C., Freitas, H. F., Campos, J. M., Kimani, N. M., Silva, C. H. T. de P. da, Borges, R. S., et al. (2021). Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro. International Journal of Molecular Sciences, 22( 21), 1-24. doi:10.3390/ijms222111739NLM
Silva RC, Freitas HF, Campos JM, Kimani NM, Silva CHT de P da, Borges RS, Pita SSR, Santos CBR. Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 21): 1-24.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/ijms222111739Vancouver
Silva RC, Freitas HF, Campos JM, Kimani NM, Silva CHT de P da, Borges RS, Pita SSR, Santos CBR. Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 21): 1-24.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/ijms222111739
